A series of cellular experiments related to cell proliferation and ferroptosis, and mouse tumor‐bearing experiments were performed to investigate the role of USP22 in hepatocellular carcinoma cell growth and Sorafenib resistance. This evidence concerns the gene USP22 and hepatocellular carcinoma.